Brief: vTv Therapeutics Announces 2022 Third Quarter Financial Results And Provides Corporate Update
10/11/2022 22:46
Nov 10 (Reuters) - vTv Therapeutics Inc VTVT.O :
* VTV THERAPEUTICS ANNOUNCES 2022 THIRD QUARTER FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
* VTV THERAPEUTICS INC - QTRLY LOSS PER SHARE OF $0.05 PER
BASIC
SHARE
* VTV THERAPEUTICS INC - COMPANY'S CASH POSITION AS OF
SEPTEMBER
30, 2022, WAS $15.3 MILLION COMPARED TO $13.4 MILLION AS OF
DECEMBER 31, 2021
Source text for Eikon: ID:nGNX2xYHSY
Further company coverage: VTVT.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on vTv Therapeutics
See all newsBrief: Vtv Therapeutics Announces FDA Orphan Drug Designation For Hppd In Sickle Cell Disease
vTv Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
vTv Therapeutics Inc expected to post a loss of $1.04 a share - Earnings Preview
vTv Therapeutics Q2 net loss widens on higher trial costs
Brief: VTv Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)